Digestive Health

The Pharmacy Times® Digestive Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to health of the digestive system, including Crohn disease, inflammatory bowel disease, irritable bowel syndrome, and ulcerative colitis.

FDA Approves Sacrosidase to Treat Congenital Sucrase-Isomaltase Deficiency

September 07, 2022

Article

Sacrosidase was approved by the FDA to treat congenital sucrase-isomaltase deficiency, a condition that inhibits people from breaking down sucrose.

Daily Medication Pearl: Ozanimod (Zeposia)

August 31, 2022

Article

Ozanimod (Zeposia) is indicated for the treatment of multiple sclerosis and moderately to severely active ulcerative colitis in adults.

Clinical Overview: Risankizumab-rzaa for Crohn Disease

August 29, 2022

Article

Risankizumab-rzaa is the first and only specific IL-23 inhibitor approved to treat moderately to severely active Crohn disease in adults.

New Therapeutic Targets Could Treat Colon Tumors, Inflammatory Bowel Disease

August 17, 2022

Article

Scientists found that inhibiting certain immune system receptors could treat colon cancer and other diseases of the gastrointestinal tract.

Study Finds Fiber Supplements Convey Similar Benefits to Gut Health

August 12, 2022

Article

Researchers studying the gut microbiome found that fiber supplements of any kind could improve gut health.

A Step in The Right Direction: Optimization of STOPP/START Recommendations for Pharmacists

August 10, 2022

Article

Health care professionals need to work closely with patients in understanding polypharmacy and the risk/benefit of pharmacotherapy.

New Binding Mechanism Science Driving Therapeutic Insight in Immune-Mediated Diseases

August 09, 2022

Article

The ability of an anti-interleukin-23 antibody to bind to key immune system components may help neutralize a key driver of inflammation right at its cellular source.

Daily OTC Pearl: Senokot-S

August 09, 2022

Article

Senokot-S is indicated for constipation relief.

Study: Green Tea Extract Reduces Blood Sugar Levels, Improves Gut Health

August 08, 2022

Article

Investigators found that the health risks linked to the condition known as metabolic syndrome could be diminished by green tea’s anti-inflammatory benefits in the gut.

AbbVie Submits Applications to EMA, FDA for Upadacitinib to Treat Crohn Disease

August 02, 2022

Article

Submissions are based on 3 phase 3 clinical trials showing that the drug achieved the co-primary endpoints of clinical remission and endoscopic response as induction and maintenance treatment.